Articles related to ASTHMA

The working group strongly recommended inhaled corticosteroids (ICS) and streamlined management of asthma by suggesting a combination of ICS and rapid-onset long-acting β-agonist as both reliever and controller agents and step-up therapy by increasing ICS and/or adding long-acting anticholinergic agents.

“Today’s approval of the first generic fluticasone propionate inhalation aerosol represents an important step in expanding access to affordable asthma treatment.” – Iilun Murphy, MD, Director of the Office of Generic Drugs in the FDA’s Center for Drug Evaluation and Research

In pregnancy, asthma effects vary significantly: one-third of patients experience worsening symptoms, one-third improve, and one-third remain stable. Properly controlled asthma during pregnancy does not increase maternal or infant complications.

Prescription medications for smoking cessation demonstrate 2-3 times greater effectiveness compared to nicotine gum, offering a superior intervention option for asthma patients who smoke.

Laboratory analysis reveals montelukast demonstrates “significant binding” to multiple brain receptors, suggesting more extensive neurological activity than previously understood.

Measuring exhaled nitric oxide (FeNO) aids in diagnosing asthma, predicting response to corticosteroids, and monitoring treatment adherence, making it a valuable adjunctive tool in comprehensive asthma management.